Donald A. Glass II, MD, PhD, FAAD is the recipient of the first-ever Sanofi and Regeneron Diversity, Equity, and Inclusion (DEI) Mid-Career Award. The award was bestowed by the Dermatology Foundation (DF) and the Skin of Color Society (SOCS) to support Dr. Glass’ research into “Genetics, Comorbidities and their Association with Keloids.”

A nationally recognized keloids expert, Dr. Glass is an Associate Professor at the University of Texas Southwestern Medical Center in Dallas, Texas. He served as 2021-2022 President of the Skin of Color Society.

The Sanofi and Regeneron DEI Mid-Career Award was developed especially for the exceptional mid-career investigator with an established trajectory of excellence in basic, clinical or translational science. The award aims to expand the understanding of dermatological issues impacting underrepresented or underserved groups in medicine.

“The need for mid-career research funding is growing and, when provided, can spur investigators to do remarkable work. We were excited to work with the Skin of Color Society to develop a new funding source that would focus solely on research that could further health equity,” said Dr. Janet Fairley, DF President. “Our sincere congratulations to Dr. Glass, the outstanding first award recipient for this highly competitive award—and our sincere gratitude to Sanofi and Regeneron for making the award possible.”

“We are greatly honored to collaborate with the Dermatology Foundation on this important opportunity to support exemplary investigators who are dedicated to studying dermatological diseases that impact underrepresented and underserved patients of color. We congratulate Dr. Donald Glass on receiving this well-earned research award and look forward to the results of his work,” remarks Victoria Barbosa, MD, MPH, MBA, FAAD, Skin of Color Society President (2024-2025), and Associate Professor of Dermatology at the University of Chicago.

Applications for the 2025 Sanofi and Regeneron DEI Mid-Career Award cycle will open in mid-September 2024.